Ladenburg Thalmann Financial Services’s 10x Genomics TXG Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$15K	Buy	+200	New	+$12K	﹤0.01%	4296

Other funds holding TXG

FCMI

Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

JCM

JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Ladenburg Thalmann Financial Services's TXG Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in 10x Genomics (TXG) in Q4 2019: 200 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #4296 among its holdings.

85 funds tracked by Wall St. Rank hold TXG as of Q4 2019.

Ladenburg Thalmann Financial Services held 200 shares of 10x Genomics worth $15K as of Q4 2019.
10x Genomics was a new Ladenburg Thalmann Financial Services position in Q4 2019.
10x Genomics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4296 holding.
85 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.